BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  NextCure Reports Third Quarter 2020 Financial Results

  NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, reported third quarter 2020 financial results and provided a business update.

  November 5, 2020

   · 

  9 min read
• Business

  Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 Financial Guidance

  Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2020.

  November 5, 2020

   · 

  33 min read
• Business

  TrialSite News® Partners With Medical Center of the Americas Foundation to Bring Clinical Trials to the Region

  TrialSite News LLC (TrialSite), an online news and information platform dedicated to clinical research transparency and accessibility and the advancement of biomedical research, announces a partnership with the Medical Center of the Americas Foundation (MCA) in El Paso, Texas.

  November 5, 2020

   · 

  3 min read
• Business

  InMed Reschedules Reporting of First Quarter Financial Results and Business Update to November 13, 2020

  InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN) (OTCQX: IMLFF), today announced that, due to the regulatory quiet period the Company is in, it has rescheduled the reporting of its financial results for the first quarter of fiscal year 2021, ending September 30, 2020.

  November 5, 2020

   · 

  2 min read
• Drug Development

  Eisai Announces Investigational Data Highlighting LENVIMA® (lenvatinib) Based Combination Therapy in Patients With Renal Cell Carcinoma at IKCS 2020

  Eisai will present seven abstracts at the International Kidney Cancer Symposium (IKCS) 2020 from November 6-7, 202

  November 5, 2020

   · 

  21 min read
• Business

  Cryoport Reports 2020 Third-Quarter Results

  Acquired MVE Biological Solutions and CRYOPDP advancing Cryoport’s position as the global leader in temperature-controlled supply chain solutions for the life sciences industry

  November 5, 2020

   · 

  18 min read
• Business

  Theravance Biopharma, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

  YUPELRI® (revefenacin) share of the nebulized COPD market increased to 17.4% through July 2020 (up from 16% in April 2020) and achieved brand profitability on a stand-alone basis

  November 5, 2020

   · 

  22 min read
• Business

  Ironwood Pharmaceuticals Appoints Alexander Denner, Ph.D., to Board of Directors

  Ironwood Pharmaceuticals, Inc. announced the appointment of Alexander Denner, Ph.D., to its Board of Directors, effective November 9, 2020.

  November 5, 2020

   · 

  5 min read
• Business

  AtriCure Reports Third Quarter 2020 Financial Results

  AtriCure, Inc., a leading innovator in treatments for atrial fibrillation and left atrial appendage management, announced third quarter 2020 financial results.

  November 5, 2020

   · 

  10 min read
• Business

  Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates

  FDA grants two Orphan Drug Designations to KZR-616 for the treatment of Dermatomyositis (DM) and Polymyositis (PM)

  November 5, 2020

   · 

  10 min read